Rx drug information, pharmaceutical research, clinical trials, news, and more
Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial [Completed]
Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily [Completed]
Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial [Completed]
Trospium Chloride XR in Obese Female Patients With Overactive Bladder [Completed]
The Effect of Anticholinergics on Cognitive Function in the Elderly [Completed]
ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD [Completed]
Anticholinergic vs. Botox Comparison Study [Completed]
Study of Trospium Chloride Inhalation Powder (TrIP) in Patients With Chronic Obstructive Pulmonary Disease [Completed]
Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor Overactivity [Completed]
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) [Recruiting]
Urinary Nerve Growth Factor (NGF), Prostaglandin E2 (PGE2)and Adenosine Triphosphate (ATP): Potential Biomarkers in Overactive Bladder Patients [Recruiting]
InSite for Over Active Bladder [Active, not recruiting]
All Rights reserved - Copyright DrugLib.com, 2006-2017